Biogen Inc. technical analysis
Technical analysis of Biogen Inc. (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
What is Biogen Inc.
Biogen Inc. is a pharmaceutical company that discovers, develops, manufactures, and delivers drugs and therapies in the healthcare sector, with a global presence in the United States, Europe, Asia, and internationally. Its product portfolio includes treatments for multiple sclerosis, spinal muscular atrophy, Alzheimer's disease, postpartum depression, lymphomas, leukemia, and other neurological and immunological conditions, as well as biosimilar medicines. The company operates through collaborations and licensing agreements with numerous pharmaceutical and biotechnology partners.
Description generated automatically from public sources; it may be inaccurate or out of date.
Biogen Inc.: latest session data
Closing values for September 4, 2026, computed on the last 12 months of prices.
Moving averages
21 sessions
215.40 $
+2.52%
50 sessions
209.53 $
+5.39%
200 sessions
191.05 $
+15.59%
Session levels
s2
219.28
Support
s1
221.89
Support
pivot
223.85
Pivot
r1
226.46
Resistance
r2
228.42
Resistance
How to read it
In the September 4, 2026 session Biogen Inc. closed lower at 220.83 $, −1.64% versus the previous session.
The price sits above every moving average observed: +2.52% against the 21-session average, +5.39% against the 50 and +15.59% against the 200.
The 14-period RSI reads 58.0, in neutral territory.
MACD stands at 4.040 against a signal line at 3.838: the histogram is positive (+0.201).
ADX reads 26.2, indicating a marked directionality.
Levels computed on the latest session place supports at 221.89 and 219.28 $ and resistances at 226.46 and 228.42 $, around a pivot of 223.85.
The average daily range (ATR) is 5.866 $, or 2.66% of price.
Turnover was 465.1K shares, 66% of the 20-session average.
Over the last twelve months the price ranged between 168.64 and 225.80 $, and today stands −2.20% from the period high.
Measures computed on closing prices. They describe the past; they are not forecasts.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the BIIB analysis.
How Montbon’s technical analysis works
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
FAQ about Biogen Inc.
How is Biogen Inc. analysed technically?
Technical analysis of Biogen Inc. is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for Biogen Inc.?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to Biogen Inc.?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Biogen Inc. it helps frame the technical structure of the historical chart and is not a forecast.
Other tickers to analyse
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.